Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF.
Kondo T, Mogensen UM, Talebi A, Gasparyan SB, Campbell RT, Docherty KF, de Boer RA, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Sabatine MS, Bengtsson O, Sjöstrand M, Vaduganathan M, Solomon SD, Jhund PS, McMurray JJ.
Kondo T, et al.
J Am Coll Cardiol. 2024 Mar 25:S0735-1097(24)06671-3. doi: 10.1016/j.jacc.2024.03.385. Online ahead of print.
J Am Coll Cardiol. 2024.
PMID: 38537918